2022Ä꣬£¬ÑۿƾµäÔÓÖ¾¡¶Cornea¡·»ØÊ×·¢Ã÷£¬£¬±»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿ÊÇ1995ÄêÉúÎïÑòĤ£¨Ì¥ÅÌÄÚ°ü¹üÑòË®µÄ±¡Ä¤£©ÓÃÓÚÑÛ±íÖØÐÞµÄÂÛÎÄ¡£¡£¡£³ýÑÛ¿ÆÍ⣬£¬ÑòĤ¿ÉÓ¦ÓÃÓÚÍâÉËÐÞ¸´¡¢¹Ç¿ÆµÈÁìÓò£¬£¬¿°³ÆÍò½ðÓÍ¡£¡£¡£È»¶ø£¬£¬ÉúÎïÑòĤÔÚÁÙÅèºóͨ³£±»¿´³ÉÒ½ÁÆ·ÏÎïÏú»Ù¡£¡£¡£ÕâÑùÒ»¸öÒ½ÁÆ·ÏÎ£¬ÊÇÔõÑùÄæÏ®µÇÉÏÊÖÊǫ̃£¬£¬³ÉΪ×îÊÜÖõÄ¿µÄÔÙÉúÖÊÁÏ£¿£¿
´Ó»ùµ×Ĥ¡¢Ó²ÄÔĤµ½Ò»Ð©Ö÷ÒªÆ÷¹Ù£¬£¬Ä¤ÆÕ±é±£´æÓÚÈËÌå¡£¡£¡£×ÔȻĤÖÊÁϾ߱¸¸ß¶ÈµÄÉúÎïÏàÈÝÐԺʹó×Ú»îÐÔÒò×Ó£¬£¬³ýÁ˸ôÀë·À»¤×÷Ó㬣¬»¹¿ÉÒÔ×÷ΪÔÙÉúÖÊÁÏ¡£¡£¡£
ÒÑÍùÒ»°ÙÄêÖУ¬£¬ÈËÀàʵÑé°ÑÖÖÖÖÉúÎïĤÓÃ×÷ÐÞ¸´ÔÙÉú£¬£¬´ÓƤ·ô¡¢½ÇĤµ½¿ÚÇ»£¬£¬´ÓÈËÌåµ½ÖíС³¦ð¤Ä¤¡¢Ð¡Å£ÕæÆ¤ÉõÖÁ¼¦µ°Ä¤¡£¡£¡£ÖîÈçÖíϲãð¤Ä¤µÈ×ÔȻĤÒѱ»ÓÃ×÷ðÞ²¹Æ¬¡¢Ó²ÄÔĤ¡¢¿ÚǻĤµÈ£¬£¬ÔÐÓýÁËÕýº£ÉúÎï¡¢¹Úê»ÉúÎïµÈÉÏÊй«Ë¾¡£¡£¡£
ÔÚ×ÔȻĤÖÊÁÏÖУ¬£¬ÉúÎïÑòĤÊÇΨһ¸ôÀëÁ½Ð¡ÎÒ˽¼ÒµÄÈËÌå×éÖ¯¡£¡£¡£ÑòĤÒò°ü¹üÑòË®¶øµÃÃû£¬£¬ÊÇÌ¥ÅÌ×îÄÚ²¿µÄ͸Ã÷±¡Ä¤£¬£¬ÓëÌ¥¶ùÖ±½Ó½Ó´¥¡£¡£¡£ÑòĤ´Óϸ°û×ÌÑø²ãÑÝ»¯¶øÀ´£¬£¬¸ôÀëÁËÔи¾ÓëÌ¥¶ù£¬£¬²¢ÇÒÖ§³ÖÌ¥¶ùµÄ·¢Óý£¬£¬¾ß±¸×ÔÈ»µÄ¸ßÉúÎïÏàÈÝÐÔÓë¶à»îÐÔÒò×Ó¡£¡£¡£
ÑòĤµÄÔÙÉúҽѧDZÁ¦ÔÚ20ÊÀ¼Í³õ¼´±»¾ò¿Í¡£¡£¡£1910Ä꣬£¬Davis µÚÒ»´Î±¨µÀÁËÓòú¸¾ÑòĤ×÷ΪÍâ¿ÆÆ¤·ôÒÆÖ²µÄÖÊÁÏ£»£»£»ËæºóÑòĤÔÚÆ¤·ôÉÕÉËºÍÆ¤·ôÀ£ÑñµÄÖÎÁÆ¡¢È˹¤ÒõµÀÖÊÁÏ¡¢½ÇĤ֨ÐÞµÄÓ¦Óþù»ñµÃÀֳɡ£¡£¡£½üÎåÄêµÄÁÙ´²ÊÔÑéÖУ¬£¬ÑòĤ˳Ӧ֢¼¯ÖÐÔÚÍâÉËÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿ÆÁìÓò£¬£¬ÒÑÓÐÏà¹Ø²úÆ·ÉÏÊУ»£»£»ÔÚÃÚÄò¿Æ¡¢¿ÚÇ»ºÍÖ×ÁöÁìÓòÉÐÊôת»¯½×¶Î¡£¡£¡£Áè¼Ý 50%µÄÁÙ´²Ñо¿ÔÚÃÀ¹úÍê³É£¬£¬ÒÑÓлñÅú²úÆ·¡£¡£¡£½ôËæØÊºóµÄÖйú¡¢°£¼°¡¢Ó¡¶È¡¢ÒÁÀʺ͵¹úÒ²½«Óиü¶à²úÆ·»ñÅú¡£¡£¡£
1.1 ÑÛ¿ÆÓ¦Ó㺴µ¾¡»ÆÉ³Ê¼µ½½ð
1940 Ä꣬£¬De Roth Ê״ν«ÑòĤӦÓÃÓÚÑÛ²¿£¬£¬ÐÞ¸´½áĤȱË𡣡£¡£½Ç½áĤÉÏÆ¤È±Ë𱬷¢ÓÚÉÕÉË¡¢À£Ññ¡¢Òí×´æÀÈâÊõºó¡¢±í²ã½ÇĤÇü¹âÊõºóµÈ¡£¡£¡£¹Å°åµÄÑÛ±íÖØÐÞ½ÓÄÉļ¾èȪԴµÄ½ÇĤºÍ×ÔÌå½áÄ¤ÒÆÖ²£¬£¬±£´æ½ÇĤ¹©Ìå½ôȱºÍ×ÔÌå½áĤÔì³ÉÒ½Ô´ÐÔËðÉ˵ÈÎÊÌâ¡£¡£¡£
ÒÀ¾Ý¾µäµÄ¡°XYZ¼Ù˵¡±£¬£¬ÑÛÇòĤµÄÍêÕûÒÀÀµÓÚÔÙÉúÆøÖÆ£¬£¬´ó×ÚÉÏÆ¤Ï¸°ûµÄËðʧÓë¿ìËÙÔÙÉú¸æ¿¢Æ½ºâ¡£¡£¡£µ±·ºÆð×é֯ȱËð¡¢½ÇĤԵ¸Éϸ°ûÒ쳣ʱ£¬£¬ÑÛÇòµÄÔÙÉúÆøÖÆÄÑÒÔΪ¼Ì¡£¡£¡£Òò´Ë£¬£¬ÑÛÇòĤµÄÐÞ¸´¶ÔÖ¤ÁϵÄÒªÇ󼫸ߡ£¡£¡£
De RothʵÑéÁËÖÖÖÖ×ÔȻĤÖÊÁϺ󣬣¬·¢Ã÷ÑòĤ¿ÉÄÜÊÇΨһµÄÀíÏëÔÙÉúÖÊÁÏ£º£¨1£© Ƥ·ô£ºÓ²ÖÊ¡¢¾ßÓÐÑÕÉ«£»£»£»£¨2£©¿ÚÇ»ð¤Ä¤£ººìÉ«¡¢³ß´çÓÐÏÞ£»£»£»£¨3£©ÒõµÀð¤Ä¤£ºÑéÖ¤ÓÐÓ㬣¬µ«¿ÉÄÜ»áÒÆÖ²ºóËõ¶Ì£»£»£»£¨4£©°üƤ£ºÐ§¹ûºÃ£¬£¬µ«»¼Õ߾ܾø´ÓÔÆÔÆÅ³ÈõµÄµØ·½ÒÆÖ²¡£¡£¡£
¶øÑòĤ¾ß±¸±¡¡¢Æ½»¬¡¢Í¸Ã÷¡¢ÎÞѪ¹ÜµÈÌØµã£¬£¬Óë½áĤ×îΪÏàËÆ£¬£¬²¢¿ÉÒÔ´ó×Ú»ñµÃ¡£¡£¡£De Roth½«ÑòĤӦÓÃÔÚÁË8̨ÊÖÊõÖУ¬£¬Ð§¹ûÏÔʾÔÚÑòĤ±»ÎüÊպ󣬣¬ÔȱËðÇøÓòÏñÕý³£½ÇĤһÑù¡£¡£¡£
ÔÚ´ËÖ®ºó£¬£¬×îÏÈÁËÑòĤÔÚÑÛ¿ÆÓ¦ÓÃµÄÆÕ±éʵÑé¡£¡£¡£µ«ÓÉÓÚÊìϤ²»Ç壬£¬´ó×ÚÑо¿»ìÓÃÁË̥Ĥ¡¢ÈÞëĤ£¨ÑòĤÃâÒßÔÐÔµÄÖ÷ҪȪԴ£©¡¢ÑòĤ£¬£¬µ¼ÖÂÑо¿Ð§¹ûÁ¼Ý¬²»Æë£¬£¬ÑòĤ²¢Ã»Óдó¹æÄ£ÆÌ¿ªÊ¹Óᣡ£¡£Ö±µ½1995Ä꣬£¬KimºÍTsengÀֳɵØÊ¹ÓÃÑòĤ¶Ô½ÇĤ¼°½ÇĤԵ¸Éϸ°ûȱËðµÄÍÃ×Ó¾ÙÐÐÒÆÖ²£¬£¬Ïà¹ØÐ§¹û½ÒÏþÓÚÑۿƾµäÔÓÖ¾¡¶Cornea¡·£¬£¬ÔÙ¶ÈÒý·¢Èȳ±¡£¡£¡£
ÔÚ2022Äê¡¶Cornea¡·»ØÊ×ÖÐÌá¼°£¬£¬KimºÍTsengµÄÕâÆªÉúÎïÑòĤÎÄÕ³ÉΪÁ˱»Òý´ÎÊý×î¶àµÄʵÑéÐÔÑо¿¡¢ÒÔ¼°±»Òý´ÎÊýµÚ¶þ¶àµÄ½ÇĤÎÄÏס£¡£¡£
ÁÙ´²Êµ¼ùÖУ¬£¬ÉúÎïÑòĤ¿ÉÓÃÓÚÒí×´æÀÈâ¡¢½ÇĤÉÏÆ¤È±Ëð¡¢Çà¹âÑÛµÈÊÖÊõ¡£¡£¡£¿ÉÒÔ˵¹Å°åµÄÒÆÖ²ÊÖÊõ¾ù¿ÉÓÃÑòÄ¤Ìæ»»»òÁªÓᣡ£¡£
ÌØÊâÊÇÒí×´æÀÈ⣬£¬º£ÄÚÄêÊÖÊõÁ¿¸ß´ï150Íǫ̀£¬£¬Í¨³£Ðд¿´âÇгýÊõ£¬£¬Ô¼Ò»°ë»¼Õ߻Ḵ·¢£»£»£»¶øÁªºÏÑòÄ¤ÒÆÖ²Êõ+Ë¿ÁÑÃ¹ËØCºó£¬£¬¸´·¢ÂʿɽµÖÁ5.8%¡£¡£¡£²¿·ÖÑо¿ÏÔʾ¸´·¢ÂÊÂÔ¸ßÓÚ×ÔÌå½áÄ¤ÒÆÖ²Êõ£¬£¬µ«µ±È±ËðÃæ»ý½Ï´óʱ£¬£¬ÑòÄ¤ÒÆÖ²×èÖ¹ÁË´óÃæ»ýÈ¡ÓýáĤÔì³ÉµÄÒ½Ô´ÐÔËðÉË£¬£¬ïÔÌñ£ºÛ»¯¡£¡£¡£²¢ÇÒæÀÈâÇгýÊõºó£¬£¬ÁªºÏ×ÔÌå½áÄ¤ÒÆÖ²¡¢ÑòÄ¤ÒÆÖ²£¬£¬¿É½µµÍÊõºóÑ×Ö¢¼¸ÂÊ£¬£¬½øÒ»²½½µµÍ¸´·¢ÂÊ¡£¡£¡£
ÉúÎïÑòĤҲ¿ÉÓÃÓÚÇà¹âÑÛÂ˹ýÊõºó£¬£¬ÓÃÀ´ÒÖÖÆñ£ºÛÐγɡ£¡£¡£È«ÇòÇà¹âÑÛ»¼²¡ÈËȺÖУ¬£¬Ô¼ËÄ·ÖÖ®Ò»µÄ»¼ÕßÀ´×ÔÖйú£¬£¬2020Äê´ï2100Íò£¬£¬ÖÂîÕßÊýµÖ´ï567Íò¡£¡£¡£Çà¹âÑÛ³£ÓÃÊõʽΪͨÀýСÁºÇгýÊõ£¬£¬ÀÖ³ÉÂʽöΪ11%~52%¡£¡£¡£½áĤÏÂÂ˹ýÅÝñ£ºÛ»¯Êǵ¼ÖÂÇà¹âÂ˹ýÊÖÊõʧ°ÜµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬£¬»¼ÕßÍùÍùÐèÒªÖØ¸´ÊÖÊõ¡£¡£¡£ÁªºÏÑòÄ¤ÒÆÖ²Êõ£¬£¬½«ÑòĤÖÃÓÚ½áĤ±ßÑØ¡¢¹®Ä¤°êÏ£¬£¬¿ÉʹÓÃÑòĤµÄ¿¹ÏËά»¯ÌØÕ÷¸ÄÉÆÔ¤ºó¡£¡£¡£
1.2 ÆäËûѧ¿Æ£ºÖ±¹ÒÔÆ·«¼Ã²×º£
ÍâÉËÐÞ¸´ºÍ¹Ç¿ÆÊÇÉúÎïÑòĤÂÊÏÈÉÌÒµ»¯µÄÁìÓò¡£¡£¡£´óÃæ»ýÉî¶ÈÉÕÉË¡¢ÄÑÓúÐÔÀ£ÑñÈçÌÇÄò²¡×ãÀ£ÑñµÈÐÞ¸´ÄÑÌ⣬£¬¾ù¿ÉÓ¦ÓÃÉúÎïÑòĤ£¬£¬´Ùѧϰ¸´£¬£¬ÒÖÖÆñ£ºÛ±¬·¢¡£¡£¡£
ÉúÎïÑòĤÔÚÌåÄÚÍâͬÑù±»Ö¤Êµ¾ßÓÐÐÞ¸´¹ÇȱËð¡¢Èí¹ÇËðÉ˺ͼ¡ëìËðÉ˵ÄÄÜÁ¦¡£¡£¡£¼¡ëìËðÉËÐÞ¸´ÖУ¬£¬ËðÉ˲¿Î»·ìºÏºó°ü¹üÑòĤ£¬£¬¿ÉÏÔןÄÉÆ¾Ö²¿ð¤Á¬£¬£¬Ôö½ø¼¡ë콺ÔÏËάºÏ³É£¬£¬Ëõ¶ÌÐÞ¸´Ê±¼ä£¬£¬¼¡ëì³ÐÔØÁ¦ÏÔ×ÅÓÅÓÚͨÀý·ìºÏ¡£¡£¡£
¹ÄĤ´©¿×ÖУ¬£¬¶úÄÚ¾µÏßÏÂÉúÎïÑòÄ¤ÒÆÖ²ÐйÄĤ´©¿×ÐÞ²¹Êõ£¬£¬×èÖ¹×ÔÌåÈ¡²Ä´´ÉËÓëñ£ºÛ£¬£¬¾ßÓÐÊÖÊõ¶Ì£¬£¬³öѪÉÙµÈÓŵ㡣¡£¡£ÆäËûÁìÓòÈç±ÇÀá¹ÜÖØÐÞ¡¢Éñ¾ÎǺÏÐÞ¸´¡¢×Ó¹¬ÄÚĤÐÞ¸´µÈ¾ù¿ÉÓ¦ÓÃÑòĤ¡£¡£¡£
ÑòĤÊÇÈËÌå×îºñµÄĤ֮һ£¬£¬ÊÇÒ»ÖÖÎÞÉñ¾¡¢¼¡ÈâºÍÁܰ͹ܵİë͸Ã÷Ĥ״×éÖ¯£¬£¬Ö÷ÒªÓÉÑòĤÉÏÆ¤Ï¸°û¡¢ÑòĤ¼ä³äÖʸÉϸ°ûºÍ³ÉÏËάϸ°û×é³É¡£¡£¡£ÑòĤ×ÔÍâÏòÄÚ£¬£¬¿É·ÖΪÉÏÆ¤Ï¸°û²ã¡¢»ùµ×Ĥ¡¢ÖÂÃܲ㡢ÏËάϸ°û²ã¼°º£Ãà²ãÎå¸ö²¿·Ö¡£¡£¡£
͸Ã÷¡¢ÎÞѪ¹ÜʹÑòĤÊʺÏÒÆÖ²£»£»£»¸»ºñµÄ½ºÔÏËά°ü¹ÜÁË¿¹ÀÁ¦£»£»£»»ùµ×²ã¸»ºñµÄ°ëÇÅÁ£ÒÔ¼°ÖØ´óµÄ½ºÔÍøÂçʹÉÏÆ¤Ï¸°ûÒ×ÓÚÉú³¤¼°Õ³¸½£»£»£»ÑòĤÍâòµÄÃÔ·¹ÜµÀϵͳʹÆäÒ×ÓÚ¾ÙÐÐÎïÖʽ»Á÷£»£»£»×÷ΪͬÖÖÒìÌåÖÊÁÏ£¬£¬²»±í´ïHLA-A,B,C£¬£¬DR£¬£¬¿¹ÔÐÔ¼«µÍ£¬£¬¿É×èÖ¹ÃâÒßÇãÔþ·´Ó¦¡£¡£¡£
ÓÉÓÚÆæÒìµÄ×é֯ѧ½á¹¹¡¢·±¶àµÄ»îÐÔÒò×Ó£¬£¬ÑòĤÄܹ»Ôö½øÉÏÆ¤Ðγɣ¬£¬ÒÖÖÆÑ×Ö¢ºÍÐÂÉúѪ¹Ü¡¢ÒÖÖÆÏËά»¯¡£¡£¡£
×éÖ¯¹¤³ÌÊÖÒÕ°üÀ¨3¸öÒªËØ£¬£¬¼´Éú³¤Òò×Ó¡¢ÖÖ×Óϸ°ûºÍÖ§¼ÜÖÊÁÏ¡£¡£¡£ÔÚϸ°û²ãÃæ£¬£¬ÑòĤ¸»º¬ÑòĤÉÏÆ¤¸Éϸ°û£¨AEC£©ºÍÑòĤ¼ä³äÖʸÉϸ°û£¨AMSCs£©£¬£¬ÕâЩϸ°û¾ßÓи߶ȿÉËÜÐÔ£¬£¬ÏÔʾ¶àÏò·Ö½âDZÄÜ£¬£¬²¢ÇÒÔÚÒÆÖ²ºóûÓÐÖÂÁöΣº¦¡£¡£¡£¼ÓÖ®¸»ºñµÄϸ°ûÒò×Ó£¬£¬ÆæÒìµÄ×éÖ¯½á¹¹£¬£¬ÑòĤÊÇÀíÏëµÄÔÙÉúÖÊÁÏ¡£¡£¡£
3.1 ÉÌÆ·ÑòĤ£º×·ÇóÌù½üÐÂÏÊ״̬µÄ´¦Öóͷ£·½·¨
ÉúÎïÑòĤȡ×Ô¾èÔùµÄÌ¥ÅÌ£¬£¬ÆÊ¹¬²úºó½«ÑòĤ´ÓÈÞëĤÉÏÊèÉ¢£¬£¬¾Ï´åª¡¢Ãð¾ú£¬£¬¿ÉµÃÐÂÏÊÑòĤ¡£¡£¡£ÐÂÏÊ£¨»òÀ䲨£©ÑòĤÄܹ»×îºéÁ÷ƽ±£´æÖÖÖÖ×ÔÈ»½ºÔ¼°»îÐÔÒò×ÓÒòËØ£¬£¬Òò´ËÁÙ´²Ê¹ÓÃЧ¹û½ÏºÃ¡£¡£¡£
ÔºÄÚ×ÔÖÆÑòĤÓÉÓÚÃð»î·½·¨¼òÆÓ£¬£¬ÇÒȱÉÙÖʼ첽·¥£¬£¬ÁÙ´²Ê¹Óñ£´æÑ¬È¾Î£º¦¡£¡£¡£ÁÙ´²Ø½ÐèÌù½üÐÂÏÊÑòĤ¡¢¸üÇå¾²¡¢±ê×¼»¯µÄÑòĤÉÌÆ·£¬£¬ÌôÕ½Ö÷ÒªÀ´×ÔÓÚÈ·±£Ãð¾ú¡¢Ìù½üÐÂÏÊ״̬µÄ´¦Öóͷ£ºÍÖü´æÊÖÒÕ¡£¡£¡£
ÏÖÔÚÑòĤµÄÖü´æÒªÁìÖ÷Òª°üÀ¨¶³¸ÉºÍÀä¶³ÉúÑÄ¡£¡£¡£¶³¸ÉÊǽ«ÑòĤÔÚÔÚ -50ÖÁ-80¡ãCÏ¿ìËÙÀä¶³£¬£¬È»ºóʹÓÃÀä¶³¸ÉÔï»úÔÚ¸ßÕæ¿ÕϸÉÔï¡£¡£¡£Í¨¹ýÉý»ªÌáÈ¡×éÖ¯Öб£´æµÄË®£¬£¬ÒÔ½«Ë®º¬Á¿½µµÍÖÁ5-10%¡£¡£¡£Àä¶³ÉúÑÄÊǽ«ÑòĤÉúÑÄÔÚDMEM©U¸ÊÓͰ´1£º1±ÈÀýÅäÖÆµÄÉúÑÄÒºÖУ¬£¬²¢ÓÚ-80¡æ±ùÏäÖж³´æ£¬£¬ÓÐÓÃÆÚΪ1ÖÁ2Äê¡£¡£¡£
¶³¸ÉÑòĤËäÈ»¾ßÓÐÊÒÎÂÖü´æºÍÔËÊäµÄÓÅÊÆ£¬£¬ÓÉÓÚ¶³¸É¡¢ÍÑϸ°ûµÈ¹¤ÒÕÓ°Ï죬£¬ÁÙ´²Ð§¹ûÓëÐÂÏÊÑòĤ²îÖ®ÉõÔ¶¡£¡£¡£²»µ«ËðʧÁË´ó×ÚÓÐÓÃÒòËØ£¬£¬»¹ÈÝÒ×Ôì³ÉÂѰ×ÖʱäÐÔ¡¢ÑòĤÖÖÖÖÀí»¯ÐÔÄܽµµÍ£¬£¬Ö±½Óµ¼ÖÂÑòĤÔÚÊÖÊõÖÐÒ×˺ÁÑ£¬£¬ÐèÒªÖØ¸´Ìæ»»£¬£¬ÑÓÉìÊÖÊõʱ¼ä£»£»£»ÊõºóÑ×Ö¢·´Ó¦Ç¿ÁÒ£¬£¬ÑòĤÈÝÒ׿ìËÙ½µ½â¡¢ÍÑÂä¡£¡£¡£Òò´Ë¶³¸ÉÑòĤÖ÷ÒªÓ¦ÓÃÓÚ¶Ô»îÐÔÒò×Ó¡¢×éÖ¯½á¹¹ÒªÇó½ÏµÍµÄÉË¿ÚÕչ˻¤Ê¿¡¢¹Ç¿ÆÁìÓò£¬£¬ÉÌÆ·»¯ÑòĤ¹«Ë¾ÒÔMIMEDX£¨NASDAQ:MDXG)£©Îª´ú±í£¬£¬º£ÄÚÒÔÈð¼ÃÉúÎïΪÖ÷¡£¡£¡£
Àä¶³ÉúÑĵÄÉÌÆ·ÑòĤÒÔTissueTechΪ´ú±í£¬£¬µ«ÓÉÓÚºã¾ÃÉîµÍÎÂÉúÑı¾Ç®½Ï¸ß£¬£¬²¢ÇÒÆä¹¤ÒÕδ¶ÔÑòĤ¾ÙÐÐÃð¾úºÍ²¡¶¾Ãð»î´¦Öóͷ££¬£¬ÎÞ·¨´ó¹æÄ£Íƹ㡣¡£¡£ÑÛ¿ÆÁìÓò£¬£¬ÃÀ¹úÈÔÒÔ×ÔÖÆÑòĤΪÖ÷¡£¡£¡£
3.2 ÁÙ´²Êг¡£¡£¡£ºØ½ÐèÁ¢Òì²úÆ·ÆÆ¾Ö
¾ÝApollo Research Reportsµ÷ÑУ¬£¬2022ÄêÈ«ÇòÉúÎïÑòĤÊг¡¹æÄ£µÖ´ï32.6ÒÚÃÀÔª¡£¡£¡£Ö÷ÒªÓ¦ÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ¼°ÑÛ¿Æ¡£¡£¡£Î´À´ÑòĤ×÷Ϊ¸ßÐÔÄÜÔÙÉúҽѧÖÊÁÏ¿ÉÍØÕ¹ÖÁÊýÊ®¸öÁìÓò£¬£¬»Ý¼°ÒÚÍò»¼Õß¡£¡£¡£
ÊÂʵÉÏ£¬£¬Ö»¹ÜÁÙ´²Ö¤¾Ý¸»×㣬£¬ÊÜÏÞÓÚ¶³¸ÉÑòĤµÄÁÓÊÆ£¬£¬ÑòĤÊÖÊõÉøÍ¸ÂÊÈÔÈ»¼«µÍ¡£¡£¡£²¢ÇÒ£¬£¬ÏÖÓÐÑòĤÊÖÊõÈÔ´ó×ÚʹÓÃÔºÄÚ×ÔÐаþÖÆµÄÐÂÏÊÑòĤ»ò¸ÊÓÍÉúÑÄÑòĤ¡£¡£¡£
ÔÚÃÀ¹ú£¬£¬×Ô 2000 ÄêÒÔÀ´£¬£¬¾Ý¡¶¹«¹²ÎÀÉúЧÀÍ·¨¡·µÚ361ÌõÌõ¿î£¬£¬Õë¶Ô×ÔÌåȪԴ¡¢×îС»¯´¦Öóͷ£ºÍͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¨HCT / P£©£¬£¬ÎÞÐèÉÏÊÐÉóÅú£¬£¬½öÐ豸°¸¡£¡£¡£·ÇͬԴʹÓõÄ×é֯ϸ°û²úÆ·£¬£¬ÔòÊÊÓõÚ351Ìõ£¬£¬Æ¾Ö¤Ò½ÁƺIJľÙÐÐÁÙ´²ÊÔÑé¡£¡£¡£ÑòĤ²úÆ·Ó¦ÓÃÓÚÑÛ±í£¬£¬Ê¹ÓÃÑòĤºÍÑÛÇòĤµÄ¸ß¶ÈÏàËÆÐÔ±¬·¢×÷Ó㬣¬ÊôÓÚͬԴÓÃ;£¬£¬ÎÞÐèÉóÅú¡£¡£¡£¶øÓÃÓÚÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ£¬£¬¸ü¶àʹÓõÄÊÇÑòĤ»îÐÔÒò×Ó¶ø²»ÊÇ×éÖ¯½á¹¹×Ô¼º£¬£¬Òò´Ë²»ÊôÓÚͬԴÓÃ;¡£¡£¡£
FDAµÄÉóÅú¿íÃ⣬£¬µ¼ÖÂÁ˸߶ÈÊèÉ¢µÄÑÛ¿ÆÓÃÑòĤÊг¡£¬£¬FDA¹ÒºÅµÄÑòĤ²úÆ·¸ß´ï930ÖÖ¡£¡£¡£Òò´Ë£¬£¬ÉË¿ÚÐÞ¸´¡¢¹Ç¿Æ³ÉΪMIMEDXµÈÍ·²¿¹«Ë¾Öص㷢Á¦µÄÁìÓò¡£¡£¡£MIMEDX²úÆ·Ö÷ÒªÕë¶ÔÌÇÄò²¡×ãÀ£ÑñµÈÄÑÓúºÏÉË¿ÚÐÞ¸´¡¢ÊÖÊõÉË¿ÚÕչ˻¤Ê¿ÒÔ¼°×ãµ×½îĤÑס¢¸úëìÑ׺ÍÏ¥¹ÇÊàŦÑס£¡£¡£
ÑòĤ²úÆ·ÊôÓÚ×éÖ¯ºÍϸ°û²úÆ·£¬£¬ÍâÑó²úÆ·ÎÞ·¨½øÈëÖйú¡£¡£¡£ÔÚÎÒ¹ú£¬£¬2020Äê²ÅÓеÚÒ»¸ö¿¿½üÐÂÏÊ״̬µÄÑòĤÉÌÆ·»ñÅú¡£¡£¡£´Ëǰ£¬£¬º£ÄÚ½öÓж³¸ÉÑòĤ£¬£¬Òò´ËÑòĤÊÖÊõÒÔÔºÄÚ×ÔÖÆÎªÖ÷¡£¡£¡£ÎªÁ˰ü¹ÜÊÖÊõЧ¹û£¬£¬²¿·ÖÒ½ÉúʹÓÃ×ÔÖÆÑòĤ£¬£¬ÐèÒªÔÚÔºÄÚ´¦Öóͷ£Ì¥ÅÌ¡£¡£¡£ÓÉÓÚ×ÔÖÆ²úƷȱ·¦ÊÕ·Ñ·¾¶£¬£¬Ôڼ縺ѬȾΣº¦µÄͬʱ£¬£¬Ò½Éúȱ·¦ÓÐÓü¤Àø£¬£¬ÑòĤÊÖÊõÉøÍ¸ÄÑÌâ¡£¡£¡£
ÑòĤµÄÍÆ¹ã£¬£¬ÊÜÏÞÓÚ¶³¸É¹¤ÒÕ¡£¡£¡£Êг¡Ø½ÐèÁ¢ÒìµÄÉÌÆ·ÑòĤ£¬£¬Íê³ÉÁÙ´²¼ÛÖµÓëÉÌÒµ¼ÛÖµµÄͳһ£º
£¨1£©?ʪ̬ÑòĤ£ºÔÚÇå¾²Ìõ¼þÏ£¬£¬×îºéÁ÷ƽ±£´æÑòĤµÄ×éÖ¯½á¹¹¡¢»îÐÔÒò×Ó£¬£¬½«ÊÇÑòĤ´ó¹æÄ£ÍƹãµÄÖ÷ÒªÌõ¼þ¡£¡£¡£ÌØÊâÊÇÔÚÑÛ¿ÆÁìÓò£¬£¬¶³¸ÉÑòĤÓÐÓÃÐÔÓëÐÂÏÊÑòĤ֧¸¶ÄÑÄæ¾³£¬£¬ÐèÒªÁ¢ÒìµÄʪ̬ÑòÄ¤ÆÆ¾Ö¡£¡£¡£
£¨2£©?ÑòĤ¾µ£ºÉúÎïÑòĤÔÚÑÛ²¿µÄÁÙ´²Ó¦ÓÃÒÀÀµÓÚÊÖÊõ·ìºÏ¡£¡£¡£ÎÞ·ìÏßÀο¿Äܹ»ïÔÌÒ½ÉúµÄÉÏÊÖÄѶȡ¢ïÔÌ·ìÏߴ̼¤¡£¡£¡£ÀàËÆÒþÐÎÑÛ¾µµÄÑòĤ¾µ£¬£¬³ÉΪÃâ·ì¿ÉÅå´øµÄÁ¢Òì¼Æ»®¡£¡£¡£³ýÒí×´æÀÈâÍ⣬£¬ÑòĤ¾µ¿ÉÒÔÓ¦ÓÃÓÚ²»¾ÓÉÇå´´/¼¤¹âÖÎÁƽÇĤÇгýÊõµÄ³¡¾°£¬£¬ÔÚÃÅÕïÍê³ÉÕª´÷¡£¡£¡£Ò»¶¨Ë®Æ½ÉÏÒ²»º½âÁËDRGs/DIPË¢ÐÂÏ£¬£¬×¡ÔºÊÖÊõµÄÖ§¸¶Ñ¹Á¦¡£¡£¡£
£¨3£©?΢·ÛÑòĤ£ºMIMEDXÂÊÏÈ̽Ë÷ÁË΢·ÛÐÎʽµÄÑòĤ£¨AmnioFix Injectable£©¡£¡£¡£ÑòĤ΢·Û¾ÐÄÀíÑÎË®ÅäÖÆ¿É×¢ÉäʹÓ㬣¬Ö÷ÒªÕë¶Ô×ãµ×½îĤÑס¢¸úëìÑ׺͹ÇÊàŦÑס£¡£¡£ÏÖÔÚ½îĤÑ×ÈýÆÚÁÙ´²ÒÑÍê³É£¬£¬¸úëìÑ×½øÈëÈýÆÚÁÙ´²£¬£¬¹ÇÊàŦÑ×Ô¤¼Æ½«ÔÚ2022ÄêÆô¶¯ÈýÆÚÁÙ´²¡£¡£¡£
º£ÄÚÉúÎïÑòĤ´ú±í¹«Ë¾
½¨ÉèÓÚ2014ÄêµÄ¹ãÖÝÈðÌ©ÉúÎïÊÇÒ»¼ÒרעÓÚÑۿƺÍÔÙÉúҽѧµÄÁ¢ÒìÆ÷е¹«Ë¾¡£¡£¡£²úÆ·Ïߺ¸ÇÑÛ±í¡¢Çà¹âÑÛ¡¢Çü¹â²»Õý£¬£¬ÍÚ¾òÑۿƸßÖµºÄ²Äʱ»ú£¬£¬Ìî²¹Êг¡¿Õȱ¡£¡£¡£¹«Ë¾ÓµÓк£ÄÚÊ׸ö»ñÅúÉÏÊеÄÉúÎïʪ̬ÑòĤ£¬£¬Ê¹ÓÃÇå¾²¸ßЧµÄ´¦Öóͷ£¹¤ÒÕÅäºÏ¶À¼Ò¿ª·¢µÄÉúÑÄÒº£¬£¬´òÔì³ö»îÐÔ¿¿½üÐÂÏÊÑòĤµÄÉúÎïÑòĤ£¬£¬ÉúÑÄÓÐÓÃÆÚ³¤´ï3Äê¡£¡£¡£¹«Ë¾´ÓÔÙÉúҽѧÇÐÈ룬£¬´òÔìÑÛ¿ÆÁ¢ÒìÆ÷еƽ̨£¬£¬Ö÷Òª²úÆ·»¹°üÀ¨ÑòĤµü´ú²úÆ·ÑòĤ¾µ¡¢¹®Ä¤¾µ¡¢Çà¹âÑÛ΢֧¼ÜµÈ¡£¡£¡£
½Î÷Èð¼ÃÉúÎÐÂÈý°å£º835940£©½¨ÉèÓÚ2002Ä꣬£¬ÊÇÒ»¼Òפ×ãÓÚÔÙÉúҽѧ¼°ÉúÃü¿µ½¡¹¤Òµ£¬£¬¼¯Éú²ú¡¢Ñз¢¡¢ÏúÊÛΪһÌåµÄ¹ú¼Ò¸ßÐÂÊÖÒÕÆóÒµ¡£¡£¡£Ö÷Òª²úÆ·°üÀ¨Ñۿƶ³¸ÉÑòĤ¡¢¹Ç¿Æ¶³¸ÉÑòĤ¡¢ÑòĤÀáµÀÐÞ¸´Ö§¼ÜµÈ¡£¡£¡£Èð¼ÃÉúÎïÒÔÈËÑòĤΪÒÀÍУ¬£¬Ê¹ÓÃ×ÔÉíǿʢµÄÑз¢ÍŶӣ¬£¬ÁªºÏº£ÄÚ×ÅÃû´óѧ¡¢Ñо¿Ëù¼°Ò½ÔºÏàÖúÍê³ÉÑòĤϵÁвúÆ·µÄÉú²úºÍÑз¢¡£¡£¡£
¹ãÖÝÔÃÇåÔÙÉúҽѧ¿Æ¼¼ÓÐÏÞ¹«Ë¾½¨ÉèÓÚ2015Ä꣬£¬ÊÇÒ»¼Òפ×ãÓÚÑÛ¿ÆÔÙÉúҽѧ£¬£¬ÒÔ½¹µãרÀûÊÖÒÕΪ»ùʯ£¬£¬×¨Òµ´ÓÊÂÑÛ±íÖÎÁƼ°ÐÞ¸´¡¢ÊÓ¹âµ÷½â¡¢¸ÉÑÛµ÷ÀíµÈÖÖÖÖÑÛ¿ÆÒ½ÁÆÆ÷еÑз¢¡¢Éú²ú¼°ÏúÊÛΪһÌåµÄ¸ß¿Æ¼¼ÆóÒµ¡£¡£¡£²úÆ·°üÀ¨ÉúÎï½ÇĤ¡¢ÉúÎïÑòĤ¼°ÑÛ¿ÆÊÖÊõÆ÷е¡£¡£¡£
×ÊÁÏȪԴ£º
1. ĤÉúÎïÖÊÁϼ°ÔÚ×éÖ¯¹¤³ÌÖеÄÓ¦Ó㺡°Ö¸µ¼Ä¤ÔÙÐÄÀíÂÛ¡±µÄÕ¹Íû
2.?Update review on five top clinical applications of human amniotic membrane in regenerative medicine
3.?Transforming ocular surface stem cell research into successful clinical practice
4. ÑòĤÔÚÑÛ¿ÆÁÙ´²ÊÂÇéÖеÄÓ¦ÓÃÏ£Íû
5.?Plastic Repair of Conjunctival Defects with Fetal Membranes
6. Comment on ¡°Cornea Classic Article: Kim JC and Tseng SCG: Transplantation of Preserved Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas¡±
7.?Amniotic Membrane Grafts to Reduce Pterygium Recurrence
8.?Device©\modified trabeculectomy for glaucoma
9.?Õ׿ÆÑÛ¿ÆÕйÉÊé
10.?Recurrent Pterygium: A Review
11.?ÈËÑòĤÔڹǿÆÁìÓòµÄÑо¿Ï£Íû
12.?Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge
13.?Human Amniotic Membrane: A review on tissue engineering, application, and storage
14. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting¡ªa review
15.??HUMAN CELL AND TISSUE ESTABLISHMENT REGISTRATION
16. Amniotic Membrane and Amniotic Fluid Injections for Non Ophthalmic Applications – CAM 701149
17.? Èð¼ÃÉúÎï¹ÙÍø
18.? ÈðÌ©ÉúÎï¹ÙÍø